Bio-Rad acquires single-cell analysis company

By The Science Advisory Board staff writers

April 9, 2020 -- Bio-Rad Laboratories has acquired Celsee, a company that offers instruments and consumables for single-cell analysis.

Celsee's Genesis system helps scientists isolate, interpret, and analyze the behavior of single cells. The technology is designed for single-cell cytometry, single-cell transcriptomics, single-cell multiomics, rare-cell enrichment and enumeration, and immune monitoring.

Bio-Rad did not disclose terms of the acquisition, but it will provide further updates regarding Celsee during its first-quarter 2020 financial results call.

Shortage of RNA extraction kits threatens coronavirus testing
The weak link in the U.S. response to diagnostic testing for the novel coronavirus SARS-CoV-2 could be a shortage of RNA extraction kits. Fortunately,...
CRISPR - A New Era in Genome Editing
A major buzzword in the science world recently has been CRISPR: short for Clustered Regularly Interspaced Short Palindromic Repeats. This is a simple,...
Competition within Single-Cell Analysis Technology
The excitement surrounding the ability to measure genomic, epigenomic, transcriptomic, and metabolic status in individual cells is reflected in the high...

Copyright © 2020 scienceboard.net


Conferences
Bio-IT World Conference and Expo
September 20-22
Boston, Massachusetts United States
BioProcess International
September 20-23
Boston, Massachusetts United States
Cell and Gene Therapy Manufacturing and Commercialization
September 20-23
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter